Kenneth Reay Code - Jul 14, 2025 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, attorney-in-fact
Stock symbol
BLGO
Transactions as of
Jul 14, 2025
Transactions value $
$36,251
Form type
4
Date filed
7/16/2025, 06:21 PM
Previous filing
Jan 3, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CODE KENNETH REAY Chief Science Officer, Director 14921 CHESTNUT ST., WESTMINSTER /s/ John R. Browning, attorney-in-fact 2025-07-16 0001370684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common Stock Award $36.3K +181K +0.73% $0.20 25.1M Jul 14, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.